As a result, patients often feel full sooner and eat less throughout the day
Individuals using GLP-1 therapies may experience different levels of appetite suppression, digestive changes, and metabolic responses, making it difficult to design a one-size-fits-all nutrition solution
The clinical applications of IGF-1 LR3 span across various growth deficiencies and conditions requiring anabolic support, including hormone deficiencies leading to short stature, Turner Syndrome, muscle-wasting diseases, and conditions associated with pituitary tumors
Why Glucagon Matters Glucagon increases energy expenditure through thermogenesis, promotes hepatic fat oxidation (burning liver fat directly), mobilizes fat from adipose tissue, and reduces food intake through pathways separate from GLP-1
That means weekly shots are often needed in the beginning to keep energy and mood consistently up